Darunavir Inhibitory Quotient Predicts the 48-Week Virological Response to Darunavir-Based Salvage Therapy in Human Immunodeficiency Virus-Infected Protease Inhibitor-Experienced Patients
暂无分享,去创建一个
B. Clotet | S. Khoo | J. Moltó | N. Pérez-Álvarez | L. Else | M. Valle | C. Miranda | J. Llibre | J. R. Santos | S. Cedeño